AARTIPHARM · NIFTY
5d: -29
₹788.45-4.2%VWAP ₹823.48
A measured summary of observed signals. Not a prediction.
Trend down (10d)Volume mutedinsider net sellingFII sell streak
AI Summary
AI-generatedThe stock fell by 6.74% over the past 10 days, with a delivery percentage of 47.2%, above its 20-day average of 41.6%. The volume ratio over the last 5 days was 0.28, indicating lower trading activity.
Why did this change?
AARTIPHARM's composite score eased from 42 to 38 today (-4).
- •Price trend: trend weakened
- •Volume participation: volume held near its recent norm
- •Delivery participation: delivery participation strengthened
- •Momentum (RSI): RSI moved lower
- •Sector standing: industry standing weakened
- •Promoter pledge: promoter pledge unchanged
- •Insider activity: insider filings turned more net-buying
- •FII flow context: FII flow backdrop unchanged
The data shows the change but not its cause — several explanations are usually possible.
Tension in the data
AI-generated- ⚡ Price fell 6.7% over 10 sessions on volume well below its 20-day norm (0.3x) — thin-volume declines have historically been read as weak selling pressure.
What the data shows
- Trend (10d)
- Sector standing
- Delivery
- FII flow (5d)
- PCR
- Not available
- RSI (14)
- Promoter pledge
- Insider activity (30d)
- Event risk (5d)
Analyst checklist
- Trend
- Price fell 6.74% over the last 10 sessions.
- Volume confirmation
- Volume ran 0.28x the 5-day average — muted participation.
- Delivery quality
- Delivery held near its average (47.2% vs 41.6%).
- Sector standing
- Ranks #79 of 119 stocks measured in Biotechnology & Drugs today.
- Event risk
- No AI-classified news event matched this stock in the last 5 days.
- Growth trend
- Revenue grew 38.74% YoY last quarter — the 2th straight quarter of accelerating YoY growth.
- Valuation vs peers
- Trailing P/E of 30.63 sits below the sector average of 36.32.
Signal Change Log
- 15 Sept-410-day trend turned negative
- 11 Sept-9composite score eased 9 points on shifts across underlying measured values
- 10 Sept0FII flows ran net-negative
- 09 Sept-20trend state cleared (trend up 10d no longer applied)
- 09 Sept-20trend state cleared (above 20dma no longer applied)
- 09 Sept-20delivery state cleared (delivery up no longer applied)
- 08 Sept+410-day trend turned positive
- 07 Sept-4trend state cleared (trend up 10d no longer applied)
- 04 Sept+14delivery signal strengthened
- 02 Sept+110-day trend turned positive
- 01 Sept+8composite score rose 8 points on shifts across underlying measured values
- 28 Aug+7trend state cleared (trend down 10d no longer applied)
- 27 Aug-10composite score eased 10 points on shifts across underlying measured values
- 26 Aug+5composite score rose 5 points on shifts across underlying measured values
- 25 Aug-910-day trend turned negative
- 24 Aug0trend state cleared (trend up 10d no longer applied)
- 24 Aug-8trend state cleared (trend up 10d no longer applied)
- 24 Aug-7trend state cleared (trend up 10d no longer applied)
- 20 Aug+6composite score rose 6 points on shifts across underlying measured values
- 19 Aug-9volume fell below its recent norm
- 19 Aug-9insider filings showed net selling
- 19 Aug-9rsi state cleared (rsi overbought zone no longer applied)
- 18 Aug-11volume state cleared (volume elevated no longer applied)
- 18 Aug-11sector state cleared (sector strong no longer applied)
- 17 Aug+10price held above its 20-day average
- 17 Aug+10RSI entered its upper zone
- 17 Aug+10sector moved into the top ranks
- 17 Aug+10delivery state cleared (delivery down no longer applied)
Chart (3M daily)
Accent line: delivery % (last 21 sessions).
Related news
- mediumbusiness-standard.com· 10 Aug 2026, 02:50 pmUpper Circuit Share: Kwality Pharma, Aarti Pharmalabs, Universal Cables hit 20% upper circuits